Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001325447-11-000017
Filing Date
2011-02-11
Accepted
2011-02-11 13:48:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 ttp12311013ga.txt SC 13G/A 6414
  Complete submission text file 0001325447-11-000017.txt   8478
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 11597249
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105 212-698-3363
First Eagle Investment Management, LLC (Filed by) CIK: 0001325447 (see all company filings)

EIN.: 571156902 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A